← Evidence map

ArticleNature communications2022

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

Suyash Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35680875